1.Clinical Effect of edaravone on serum superoxide dismutase and malondialdehyde levels in elderly transient ischemic attack
Xin WANG ; Chanhong SHI ; Rongyan MAO
Chinese Journal of Geriatrics 2015;34(12):1310-1312
Objective To investigate the clinical effect of Edaravone on transient ischemic attack and serum superoxide dismutase and malondialdehyde levels in the elderly.Methods Ninety eight cases with transient ischemic attack treated in our hospital were chosen as the objects, which were randomly divided into observation group and control group (n=49 for each).Patients in observation group were treated with Edaravone combined with conventional therapy, and patients in control group were treated with conventional therapy.The clinical effect and levels of SOD and MDA were analyzed and compared between the two groups.Results The effective rate and total efficiency were higher in observation group than in control group (79.6% vs.55.1%, 95.9% vs.83.7%, x2 =6.914 and 4.354, P=0.008 and 0.032).The SOD level was higher and the MDA level was lower in observation group than in control group (both P<0.001) after treatment.Conclusions Edaravone could improve the symptoms of transient ischemic attack in the elderly, and increase the activity of SOD and reduce MDA level, which is helpful to reduce lipid peroxides, alleviate free radical toxicity, and improve the anti-oxidation ability.
2.Research progress in application of extracorporeal membrane oxygenation in patients with severe trauma
Kang LYU ; Rongyan HAN ; Guangju ZHOU ; Jiefeng XU ; Mao ZHANG
Chinese Journal of Trauma 2021;37(8):761-767
Severe trauma can result in severe respiratory and circulatory failure with a high mortality rate,which is quite difficult for clinical treatment. In recent years,the application of extracorporeal membrane oxygenation(ECMO)to circulatory and/or respiratory failure caused by severe trauma has received more and more attention. Systemic anticoagulation is often considered as a relative contraindication to ECMO therapy in patients with severe trauma who are at higher risk of bleeding. However,recent studies have shown that venovenous(VV)-ECMO is safe and feasible for treatment of severe acute respiratory failure after trauma,and venoarterial(VA)-ECMO is of great value for treatment of cardiogenic shock and traumatic cardiac arrest. The issues such as the timing of application,anticoagulation strategies,impact on survival and risk-benefit evaluation related to ECMO application to trauma care need to be investigated further. In this study,the authors summarize advances in application of ECMO,prevention and management of related complications in patients with severe trauma,so as to provide a reference for improving the application level of ECMO.